×




Massachusetts General Hospital and the Enbrel Royalty SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis

Case Study SWOT Analysis Solution

Case Study Description of Massachusetts General Hospital and the Enbrel Royalty


Massachusetts General Hospital is considering selling its royalty interest in Enbrel, Amgen's blockbuster drug for the treatment of rheumatoid arthritis. In assessing whether to sell, and at what price, the hospital must determine its value to a potential buyer as well as its own value of the royalty income.

Authors :: David S. Scharfstein, Darren R. Smart

Topics :: Finance & Accounting

Tags :: Financial management, Intellectual property, Risk management, SWOT Analysis, SWOT Matrix, TOWS, Weighted SWOT Analysis

Swot Analysis of "Massachusetts General Hospital and the Enbrel Royalty" written by David S. Scharfstein, Darren R. Smart includes – strengths weakness that are internal strategic factors of the organization, and opportunities and threats that Royalty Enbrel facing as an external strategic factors. Some of the topics covered in Massachusetts General Hospital and the Enbrel Royalty case study are - Strategic Management Strategies, Financial management, Intellectual property, Risk management and Finance & Accounting.


Some of the macro environment factors that can be used to understand the Massachusetts General Hospital and the Enbrel Royalty casestudy better are - – competitive advantages are harder to sustain because of technology dispersion, geopolitical disruptions, increasing government debt because of Covid-19 spendings, banking and financial system is disrupted by Bitcoin and other crypto currencies, digital marketing is dominated by two big players Facebook and Google, cloud computing is disrupting traditional business models, increasing household debt because of falling income levels, wage bills are increasing, increasing transportation and logistics costs, etc



12 Hrs

$59.99
per Page
  • 100% Plagiarism Free
  • On Time Delivery | 27x7
  • PayPal Secure
  • 300 Words / Page
  • Buy Now

24 Hrs

$49.99
per Page
  • 100% Plagiarism Free
  • On Time Delivery | 27x7
  • PayPal Secure
  • 300 Words / Page
  • Buy Now

48 Hrs

$39.99
per Page
  • 100% Plagiarism Free
  • On Time Delivery | 27x7
  • PayPal Secure
  • 300 Words / Page
  • Buy Now







Introduction to SWOT Analysis of Massachusetts General Hospital and the Enbrel Royalty


SWOT stands for an organization’s Strengths, Weaknesses, Opportunities and Threats . At Oak Spring University , we believe that protagonist in Massachusetts General Hospital and the Enbrel Royalty case study can use SWOT analysis as a strategic management tool to assess the current internal strengths and weaknesses of the Royalty Enbrel, and to figure out the opportunities and threats in the macro environment – technological, environmental, political, economic, social, demographic, etc in which Royalty Enbrel operates in.

According to Harvard Business Review, 75% of the managers use SWOT analysis for various purposes such as – evaluating current scenario, strategic planning, new venture feasibility, personal growth goals, new market entry, Go To market strategies, portfolio management and strategic trade-off assessment, organizational restructuring, etc.




SWOT Objectives / Importance of SWOT Analysis and SWOT Matrix


SWOT analysis of Massachusetts General Hospital and the Enbrel Royalty can be done for the following purposes –
1. Strategic planning using facts provided in Massachusetts General Hospital and the Enbrel Royalty case study
2. Improving business portfolio management of Royalty Enbrel
3. Assessing feasibility of the new initiative in Finance & Accounting field.
4. Making a Finance & Accounting topic specific business decision
5. Set goals for the organization
6. Organizational restructuring of Royalty Enbrel




Strengths Massachusetts General Hospital and the Enbrel Royalty | Internal Strategic Factors
What are Strengths in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis

The strengths of Royalty Enbrel in Massachusetts General Hospital and the Enbrel Royalty Harvard Business Review case study are -

Analytics focus

– Royalty Enbrel is putting a lot of focus on utilizing the power of analytics in business decision making. This has put it among the leading players in the industry. The technology infrastructure suggested by David S. Scharfstein, Darren R. Smart can also help it to harness the power of analytics for – marketing optimization, demand forecasting, customer relationship management, inventory management, information sharing across the value chain etc.

Training and development

– Royalty Enbrel has one of the best training and development program in the industry. The effectiveness of the training programs can be measured in Massachusetts General Hospital and the Enbrel Royalty Harvard Business Review case study by analyzing – employees retention, in-house promotion, loyalty, new venture initiation, lack of conflict, and high level of both employees and customer engagement.

Organizational Resilience of Royalty Enbrel

– The covid-19 pandemic has put organizational resilience at the centre of everthing that Royalty Enbrel does. Organizational resilience comprises - Financial Resilience, Operational Resilience, Technological Resilience, Organizational Resilience, Business Model Resilience, and Reputation Resilience.

Low bargaining power of suppliers

– Suppliers of Royalty Enbrel in the sector have low bargaining power. Massachusetts General Hospital and the Enbrel Royalty has further diversified its suppliers portfolio by building a robust supply chain across various countries. This helps Royalty Enbrel to manage not only supply disruptions but also source products at highly competitive prices.

Cross disciplinary teams

– Horizontal connected teams at the Royalty Enbrel are driving operational speed, building greater agility, and keeping the organization nimble to compete with new competitors. It helps are organization to ideate new ideas, and execute them swiftly in the marketplace.

Highly skilled collaborators

– Royalty Enbrel has highly efficient outsourcing and offshoring strategy. It has resulted in greater operational flexibility and bringing down the costs in highly price sensitive segment. Secondly the value chain collaborators of the firm in Massachusetts General Hospital and the Enbrel Royalty HBR case study have helped the firm to develop new products and bring them quickly to the marketplace.

Ability to lead change in Finance & Accounting field

– Royalty Enbrel is one of the leading players in its industry. Over the years it has not only transformed the business landscape in its segment but also across the whole industry. The ability to lead change has enabled Royalty Enbrel in – penetrating new markets, reaching out to new customers, and providing different value propositions to different customers in the international markets.

Digital Transformation in Finance & Accounting segment

- digital transformation varies from industry to industry. For Royalty Enbrel digital transformation journey comprises differing goals based on market maturity, customer technology acceptance, and organizational culture. Royalty Enbrel has successfully integrated the four key components of digital transformation – digital integration in processes, digital integration in marketing and customer relationship management, digital integration into the value chain, and using technology to explore new products and market opportunities.

Successful track record of launching new products

– Royalty Enbrel has launched numerous new products in last few years, keeping in mind evolving customer preferences and competitive pressures. Royalty Enbrel has effective processes in place that helps in exploring new product needs, doing quick pilot testing, and then launching the products quickly using its extensive distribution network.

Strong track record of project management

– Royalty Enbrel is known for sticking to its project targets. This enables the firm to manage – time, project costs, and have sustainable margins on the projects.

Diverse revenue streams

– Royalty Enbrel is present in almost all the verticals within the industry. This has provided firm in Massachusetts General Hospital and the Enbrel Royalty case study a diverse revenue stream that has helped it to survive disruptions such as global pandemic in Covid-19, financial disruption of 2008, and supply chain disruption of 2021.

Learning organization

- Royalty Enbrel is a learning organization. It has inculcated three key characters of learning organization in its processes and operations – exploration, creativity, and expansiveness. The work place at Royalty Enbrel is open place that encourages instructiveness, ideation, open minded discussions, and creativity. Employees and leaders in Massachusetts General Hospital and the Enbrel Royalty Harvard Business Review case study emphasize – knowledge, initiative, and innovation.






Weaknesses Massachusetts General Hospital and the Enbrel Royalty | Internal Strategic Factors
What are Weaknesses in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis

The weaknesses of Massachusetts General Hospital and the Enbrel Royalty are -

Low market penetration in new markets

– Outside its home market of Royalty Enbrel, firm in the HBR case study Massachusetts General Hospital and the Enbrel Royalty needs to spend more promotional, marketing, and advertising efforts to penetrate international markets.

Interest costs

– Compare to the competition, Royalty Enbrel has borrowed money from the capital market at higher rates. It needs to restructure the interest payment and costs so that it can compete better and improve profitability.

Slow to harness new channels of communication

– Even though competitors are using new communication channels such as Instagram, Tiktok, and Snap, Royalty Enbrel is slow explore the new channels of communication. These new channels of communication mentioned in marketing section of case study Massachusetts General Hospital and the Enbrel Royalty can help to provide better information regarding products and services. It can also build an online community to further reach out to potential customers.

Slow decision making process

– As mentioned earlier in the report, Royalty Enbrel has a very deliberative decision making approach. This approach has resulted in prudent decisions, but it has also resulted in missing opportunities in the industry over the last five years. Royalty Enbrel even though has strong showing on digital transformation primary two stages, it has struggled to capitalize the power of digital transformation in marketing efforts and new venture efforts.

Aligning sales with marketing

– It come across in the case study Massachusetts General Hospital and the Enbrel Royalty that the firm needs to have more collaboration between its sales team and marketing team. Sales professionals in the industry have deep experience in developing customer relationships. Marketing department in the case Massachusetts General Hospital and the Enbrel Royalty can leverage the sales team experience to cultivate customer relationships as Royalty Enbrel is planning to shift buying processes online.

Ability to respond to the competition

– As the decision making is very deliberative, highlighted in the case study Massachusetts General Hospital and the Enbrel Royalty, in the dynamic environment Royalty Enbrel has struggled to respond to the nimble upstart competition. Royalty Enbrel has reasonably good record with similar level competitors but it has struggled with new entrants taking away niches of its business.

No frontier risks strategy

– After analyzing the HBR case study Massachusetts General Hospital and the Enbrel Royalty, it seems that company is thinking about the frontier risks that can impact Finance & Accounting strategy. But it has very little resources allocation to manage the risks emerging from events such as natural disasters, climate change, melting of permafrost, tacking the rise of artificial intelligence, opportunities and threats emerging from commercialization of space etc.

Increasing silos among functional specialists

– The organizational structure of Royalty Enbrel is dominated by functional specialists. It is not different from other players in the Finance & Accounting segment. Royalty Enbrel needs to de-silo the office environment to harness the true potential of its workforce. Secondly the de-silo will also help Royalty Enbrel to focus more on services rather than just following the product oriented approach.

High dependence on star products

– The top 2 products and services of the firm as mentioned in the Massachusetts General Hospital and the Enbrel Royalty HBR case study still accounts for major business revenue. This dependence on star products in has resulted into insufficient focus on developing new products, even though Royalty Enbrel has relatively successful track record of launching new products.

Skills based hiring

– The stress on hiring functional specialists at Royalty Enbrel has created an environment where the organization is dominated by functional specialists rather than management generalist. This has resulted into product oriented approach rather than marketing oriented approach or consumers oriented approach.

Slow to strategic competitive environment developments

– As Massachusetts General Hospital and the Enbrel Royalty HBR case study mentions - Royalty Enbrel takes time to assess the upcoming competitions. This has led to missing out on atleast 2-3 big opportunities in the industry in last five years.




Opportunities Massachusetts General Hospital and the Enbrel Royalty | External Strategic Factors
What are Opportunities in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis


The opportunities highlighted in the Harvard Business Review case study Massachusetts General Hospital and the Enbrel Royalty are -

Harnessing reconfiguration of the global supply chains

– As the trade war between US and China heats up in the coming years, Royalty Enbrel can build a diversified supply chain model across various countries in - South East Asia, India, and other parts of the world. This reconfiguration of global supply chain can help, as suggested in case study, Massachusetts General Hospital and the Enbrel Royalty, to buy more products closer to the markets, and it can leverage its size and influence to get better deal from the local markets.

Reforming the budgeting process

- By establishing new metrics that will be used to evaluate both existing and potential projects Royalty Enbrel can not only reduce the costs of the project but also help it in integrating the projects with other processes within the organization.

Building a culture of innovation

– managers at Royalty Enbrel can make experimentation a productive activity and build a culture of innovation using approaches such as – mining transaction data, A/B testing of websites and selling platforms, engaging potential customers over various needs, and building on small ideas in the Finance & Accounting segment.

Redefining models of collaboration and team work

– As explained in the weaknesses section, Royalty Enbrel is facing challenges because of the dominance of functional experts in the organization. Massachusetts General Hospital and the Enbrel Royalty case study suggests that firm can utilize new technology to build more coordinated teams and streamline operations and communications using tools such as CAD, Zoom, etc.

Using analytics as competitive advantage

– Royalty Enbrel has spent a significant amount of money and effort to integrate analytics and machine learning into its operations in the sector. This continuous investment in analytics has enabled, as illustrated in the Harvard case study Massachusetts General Hospital and the Enbrel Royalty - to build a competitive advantage using analytics. The analytics driven competitive advantage can help Royalty Enbrel to build faster Go To Market strategies, better consumer insights, developing relevant product features, and building a highly efficient supply chain.

Finding new ways to collaborate

– Covid-19 has not only transformed business models of companies in Finance & Accounting industry, but it has also influenced the consumer preferences. Royalty Enbrel can tie-up with other value chain partners to explore new opportunities regarding meeting customer demands and building a rewarding and engaging relationship.

Buying journey improvements

– Royalty Enbrel can improve the customer journey of consumers in the industry by using analytics and artificial intelligence. Massachusetts General Hospital and the Enbrel Royalty suggest that firm can provide automated chats to help consumers solve their own problems, provide online suggestions to get maximum out of the products and services, and help consumers to build a community where they can interact with each other to develop new features and uses.

Lowering marketing communication costs

– 5G expansion will open new opportunities for Royalty Enbrel in the field of marketing communication. It will bring down the cost of doing business, provide technology platform to build new products in the Finance & Accounting segment, and it will provide faster access to the consumers.

Developing new processes and practices

– Royalty Enbrel can develop new processes and procedures in Finance & Accounting industry using technology such as automation using artificial intelligence, real time transportation and products tracking, 3D modeling for concept development and new products pilot testing etc.

Loyalty marketing

– Royalty Enbrel has focused on building a highly responsive customer relationship management platform. This platform is built on in-house data and driven by analytics and artificial intelligence. The customer analytics can help the organization to fine tune its loyalty marketing efforts, increase the wallet share of the organization, reduce wastage on mainstream advertising spending, build better pricing strategies using personalization, etc.

Changes in consumer behavior post Covid-19

– Consumer behavior has changed in the Finance & Accounting industry because of Covid-19 restrictions. Some of this behavior will stay once things get back to normal. Royalty Enbrel can take advantage of these changes in consumer behavior to build a far more efficient business model. For example consumer regular ordering of products can reduce both last mile delivery costs and market penetration costs. Royalty Enbrel can further use this consumer data to build better customer loyalty, provide better products and service collection, and improve the value proposition in inflationary times.

Leveraging digital technologies

– Royalty Enbrel can leverage digital technologies such as artificial intelligence and machine learning to automate the production process, customer analytics to get better insights into consumer behavior, realtime digital dashboards to get better sales tracking, logistics and transportation, product tracking, etc.

Use of Bitcoin and other crypto currencies for transactions

– The popularity of Bitcoin and other crypto currencies as asset class and medium of transaction has opened new opportunities for Royalty Enbrel in the consumer business. Now Royalty Enbrel can target international markets with far fewer capital restrictions requirements than the existing system.




Threats Massachusetts General Hospital and the Enbrel Royalty External Strategic Factors
What are Threats in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis


The threats mentioned in the HBR case study Massachusetts General Hospital and the Enbrel Royalty are -

Aging population

– As the populations of most advanced economies are aging, it will lead to high social security costs, higher savings among population, and lower demand for goods and services in the economy. The household savings in US, France, UK, Germany, and Japan are growing faster than predicted because of uncertainty caused by pandemic.

Instability in the European markets

– European Union markets are facing three big challenges post Covid – expanded balance sheets, Brexit related business disruption, and aggressive Russia looking to distract the existing security mechanism. Royalty Enbrel will face different problems in different parts of Europe. For example it will face inflationary pressures in UK, France, and Germany, balance sheet expansion and demand challenges in Southern European countries, and geopolitical instability in the Eastern Europe.

High dependence on third party suppliers

– Royalty Enbrel high dependence on third party suppliers can disrupt its processes and delivery mechanism. For example -the current troubles of car makers because of chip shortage is because the chip companies started producing chips for electronic companies rather than car manufacturers.

Consumer confidence and its impact on Royalty Enbrel demand

– There is a high probability of declining consumer confidence, given – high inflammation rate, rise of gig economy, lower job stability, increasing cost of living, higher interest rates, and aging demography. All the factors contribute to people saving higher rate of their income, resulting in lower consumer demand in the industry and other sectors.

Environmental challenges

– Royalty Enbrel needs to have a robust strategy against the disruptions arising from climate change and energy requirements. EU has identified it as key priority area and spending 30% of its 880 billion Euros European post Covid-19 recovery funds on green technology. Royalty Enbrel can take advantage of this fund but it will also bring new competitors in the Finance & Accounting industry.

Stagnating economy with rate increase

– Royalty Enbrel can face lack of demand in the market place because of Fed actions to reduce inflation. This can lead to sluggish growth in the economy, lower demands, lower investments, higher borrowing costs, and consolidation in the field.

Learning curve for new practices

– As the technology based on artificial intelligence and machine learning platform is getting complex, as highlighted in case study Massachusetts General Hospital and the Enbrel Royalty, Royalty Enbrel may face longer learning curve for training and development of existing employees. This can open space for more nimble competitors in the field of Finance & Accounting .

Technology disruption because of hacks, piracy etc

– The colonial pipeline illustrated, how vulnerable modern organization are to international hackers, miscreants, and disruptors. The cyber security interruption, data leaks, etc can seriously jeopardize the future growth of the organization.

Increasing wage structure of Royalty Enbrel

– Post Covid-19 there is a sharp increase in the wages especially in the jobs that require interaction with people. The increasing wages can put downward pressure on the margins of Royalty Enbrel.

Increasing international competition and downward pressure on margins

– Apart from technology driven competitive advantage dilution, Royalty Enbrel can face downward pressure on margins from increasing competition from international players. The international players have stable revenue in their home market and can use those resources to penetrate prominent markets illustrated in HBR case study Massachusetts General Hospital and the Enbrel Royalty .

Capital market disruption

– During the Covid-19, Dow Jones has touched record high. The valuations of a number of companies are way beyond their existing business model potential. This can lead to capital market correction which can put a number of suppliers, collaborators, value chain partners in great financial difficulty. It will directly impact the business of Royalty Enbrel.

New competition

– After the dotcom bust of 2001, financial crisis of 2008-09, the business formation in US economy had declined. But in 2020 alone, there are more than 1.5 million new business applications in United States. This can lead to greater competition for Royalty Enbrel in the Finance & Accounting sector and impact the bottomline of the organization.

Easy access to finance

– Easy access to finance in Finance & Accounting field will also reduce the barriers to entry in the industry, thus putting downward pressure on the prices because of increasing competition. Royalty Enbrel can utilize it by borrowing at lower rates and invest it into research and development, capital expenditure to fortify its core competitive advantage.




Weighted SWOT Analysis of Massachusetts General Hospital and the Enbrel Royalty Template, Example


Not all factors mentioned under the Strengths, Weakness, Opportunities, and Threats quadrants in the SWOT Analysis are equal. Managers in the HBR case study Massachusetts General Hospital and the Enbrel Royalty needs to zero down on the relative importance of each factor mentioned in the Strengths, Weakness, Opportunities, and Threats quadrants. We can provide the relative importance to each factor by assigning relative weights. Weighted SWOT analysis process is a three stage process –

First stage for doing weighted SWOT analysis of the case study Massachusetts General Hospital and the Enbrel Royalty is to rank the strengths and weaknesses of the organization. This will help you to assess the most important strengths and weaknesses of the firm and which one of the strengths and weaknesses mentioned in the initial lists are marginal and can be left out.

Second stage for conducting weighted SWOT analysis of the Harvard case study Massachusetts General Hospital and the Enbrel Royalty is to give probabilities to the external strategic factors thus better understanding the opportunities and threats arising out of macro environment changes and developments.

Third stage of constructing weighted SWOT analysis of Massachusetts General Hospital and the Enbrel Royalty is to provide strategic recommendations includes – joining likelihood of external strategic factors such as opportunities and threats to the internal strategic factors – strengths and weaknesses. You should start with external factors as they will provide the direction of the overall industry. Secondly by joining probabilities with internal strategic factors can help the company not only strategic fit but also the most probably strategic trade-off that Royalty Enbrel needs to make to build a sustainable competitive advantage.



--- ---

MF Global: Where's the Money? SWOT Analysis / TOWS Matrix

Clayton Rose, Pamela Chan, Raghav Chopra , Finance & Accounting


Biocon: From Generics Manufacturing to Biopharmaceutical Innovation SWOT Analysis / TOWS Matrix

Jeroen Van Den Berg, Michael J. Enright, Venkat Subramanian , Strategy & Execution


Beverly Stern: Retail Executive SWOT Analysis / TOWS Matrix

H. Kent Bowen, Alison Berkley Wagonfeld , Organizational Development


HomeZilla: Attracting Homebuyers through Better Photos SWOT Analysis / TOWS Matrix

Gregory S. Zaric, Hongmei Sun , Leadership & Managing People


Transformation of Pratt & Whitney North Haven (E) SWOT Analysis / TOWS Matrix

H. Kent Bowen, Linda A. Hill, Andrew Burtis, Sylvie Ryckebusch , Technology & Operations


Advanced Logic Functions in Microsoft Excel SWOT Analysis / TOWS Matrix

Kyle Maclean, Lauren E. Cipriano, Gregory S. Zaric, John Lyons , Technology & Operations